Another study of 68 Stages I and II endometrial cancer also reported the number of cancers with positive HER-2 staining to be greater tumors with ≥50% myometrial invasion compared to ≤50% myometrial invasion [43]. This evidence concerns the gene ERBB2 and endometrial cancer.